Recherche

If your doctor recently prescribed surgery with a local anaesthetic or pain treatment, a nurse or coordinator arranges with you the date when it will take place as well as any necessary pre-operative examinations. Blood tests can be carried out at the testing centre on the ground floor of the General Hospital (route 88).  Also remember to: Contact your mutual health insurance Contact your complementary health insurance if you have one Check the clauses in your contract with your broker so as to be sure what costs this insurance will cover.  If you have any questions on these subjects please contact Day Hospital Admissions on +32 (0)2 555 85 00

The Surgical Day Hospital will text or phone you the working day before the surgery to tell you the exact time you should report to the hospital reception. If there is any change of telephone number please notify the Day Hospital as soon as possible on + 32 (0)2 555 85 00 Remember to bring certain documents: Your identity card Any certificate attesting to being unfit for work provided by your employer Your insurance documents A document from your employer in case of an accident at work, for example The consent form, duly completed and sign The prescription from the doctor who is referring you if your appointment was prescribed by a doctor external to the Erasmus Hospital.  Also remember to: Take a shower with neutral soap Brush your teeth correctly Cut your finger and toe nails Remove any jewellery, piercings, make-up, nail varnish and false nails in resin, contact lenses, etc. Have a 1 euro coin for the cloakroom Bring your personal effects

To complete your registration and file, please go directly to the Surgical Day Hospital reception desk at the exact time notified. In the case of a child: Report your arrival at the Day Hospital admissions Before and after surgery your child will be examined by an anaesthetist who may administer premedication prior to the move to the operating theatre.   You can remain with your child at all times, except during the surgery itself.  An infrastructure adapted to the child's age is provided (max. 2 adults).  The length of your stay will vary depending on the treatment.   For pain treatment, it is between 1 and 2 hours depending on the type of intervention For surgery or endoscopy it is between 1 and 5 hours depending on the type of intervention If the doctor considers it necessary your stay can be extended with hospitalisation.  On departure you will receive all the instructions needed for continued home treatment and pain relief.  Remember to request the following documents: Personal documents Discharge letter to be passed on to your GP Certificate of incapacity Your insurance documents if applicable Specific documents for home care if applicable

Sharing your medical data To optimise the exchange of patient data and files between the hospital and GPs, the Erasmus Hospital participates in the Brussels Health Network. This centralised platform enables any doctor in Belgium to consult your medical file in complete security Do you want to register? There are several ways:  Via hospital admissions Via the RSB online platform Via your GP, pharmacist or mutual health insurance

Respect for your philosophical, moral or religious beliefs is a priority for us. At your request you will be able to receive a visit from a minister of religion or secular counsellor. To do so, please fill in the form you will receive at the time of admission and submit it to us in a sealed envelope. If your beliefs change, please feel free to discuss this at your care unit secretariat. You can change your mind at any time and inform us of this. * You will find hereunder the names and telephone numbers of persons who are at your disposal at the hospital. You can also request a visit from another representative of your religion or another secular counsellor. In this case, please let us have his or her name, address and telephone number, if you have it. We will try to respond to your request insofar as is possible. * According to the Ministerial Circular of 5 April 1970, amended by the Ministerial Circular of 13 March 1997 Secular counsellors Monsieur Marc Mayer +32 478 93 23 72 Secular counsellors Madame Chloé DHEUR +32 475 90 09 60 Catholic faith Monsieur Grégoire BARTHELEMY +32 2 555 44 38 Catholic faith Madame Valérie GEVAERT +32 2 555 57 78 Catholic faith Madame Micheli de VILLERS +32 2 555 57 78 Jewish faith Monsieur Bernard JOB +32 2 537 49 69 Jewish faith Monsieur Marc NEIGER (Rabbin) +32 2 332 25 28 Jewish faith Monsieur Albert GUIGUI (Grand Rabbin) +32 2 512 43 34 Muslim faith Monsieur Ibrahim BOUHNA +32 495 60 68 91 Muslim faith Madame Mouna RIDAI +32 475 44 51 70 Protestant faith Monsieur Bernard LOCOGE +32 486 42 70 50 Protestant faith Madame Joëlle MAYSTADT +32 478 26 98 34 Protestant faith Canon John WILKINSON +32 2 511 71 83 +32 478 45 51 44

Prostate cancer is the most common cancer in men, currently affecting 1 in 10 men in Belgium. Thanks to the expertise of multidisciplinary teams and the effectiveness of innovative methods, the Jules Bordet Institute, as the Brussels University Hospital (U.U.B) Cancer Centre, proposes ultra-personalised patient care and is adopting a pioneering role, nationally and internationally, in cancer care and research in the field of prostate cancer screening, diagnosis and treatment. More targeted diagnosis with the PANDORA study  A number of tests are required to diagnose prostate cancer, starting with measuring PSA levels in the blood and a digital rectal examination. If these examinations indicate a suspected cancer, an MRI can be carried out, in some cases followed by a prostate biopsy (removal of tiny samples of prostate tissue) to confirm and refine the result. The prostate biopsy is the key examination in the prostate diagnosis as it alone can confirm the presence of a cancer and is an essential factor when deciding on the treatment options. However, this biopsy can cause discomfort to patients, present a risk of complications (infection, bleeding) and sometimes reveal indolent tumours that do not require treatment. Experts at the Brussels University Hospital are therefore exploring alternatives to the biopsy. The PANDORA study, supported by the Jules Bordet Association, the Erasmus Fund and the Belgian Association of Urology, is posing the hypothesis that by including a PSMA PET/MRI in the  diagnosis tests it will be easier to effectively select patients who genuinely need a prostate biopsy  and therefore avoid unnecessary biopsies.  “This method combines the detection of an overexpressed protein in prostate cancer cells (PSMA) by means of positron emission tomography (PET) and the carrying out of a prostate MRI,” explains Romain Diamand, the PANDORA study investigator. Although at present it is used primarily to identify a recurrence of prostate cancer, it seems that this examination is also very promising for assisting in the initial diagnosis of this type of cancer.    More effective radiotherapy treatment thanks to an MRI-Linac   Thanks to its expertise and multidisciplinarity, the Jules Bordet Institute is able to offer ultra- personalised prostate cancer care. Since acquiring the MRI-Linac 1.5 T, with the support of the Jules Bordet Association, the progress in radiotherapy treatment has been nothing less than remarkable. This machine, the only one of its kind in Belgium, combines the power of a linear accelerator with the image quality of an MRI to provide tumour images in real time and thus a more precise targeting of  radiotherapy. “For the patient, this kind of ultra-personalised treatment that can be adapted daily makes it possible to spare a maximum of healthy tissue, reduce the risks of toxicity compared to conventional machines and, for some prostate cancers, reduce the number of radiotherapy sessions to 5, “ explains François Xavier Otte, radiotherapist at the Jules Bordet Institute.   Hopes for minimally invasive treatment: focal therapy  Focal therapy is a minimally invasive treatment that can be prescribed as an alternative to surgery or radiotherapy for small tumours caught at an early stage. The principle is to treat  the cancer zone and leave the rest of the prostate intact and thereby avoid risks of impotence and incontinence. There are several types of focal therapy: ultrasound, cryotherapy and laser. The Jules Bordet Institute is the only centre in Belgium to propose focal therapy using HIFU (High Intensity Focal Ultrasounds) technology that employs high energy ultrasound to destroy the disease. Research into focal therapies is very promising and a number of trials are in progress to validate new protocols. Microwave ablation has already shown its effectiveness in treating a number of organs. “The VIOLETTE study is seeking to prove its effectiveness in treating prostate cancer thanks to ultra-focal therapy with a microwave ablation protocol with image fusion so as to achieve a very precise  elimination of the tumour core, thereby neutralising it without harming the prostate functions,” explains Alexandre Peltier, urologist and principal investigator with the VIOLETTE study. 

ClinicalTRials.gov links up patients and hospitals in the interests of clinical research  The Brussels University Hospital, consisting of the Erasmus Hospital, the Jules Bordet Institute and the Queen Fabiola Children's University Hospital (HUDERF), is teaming up with Esperity to launch a Belgian portal presenting the clinical trials conducted at the three hospitals. The symbolic launch date is 20 May, on the occasion of international clinical trials day. A platform that aims to better inform patients of the clinical trials open at our hospitals.    More than an information platform, a genuine research portal    Innovative medicines are essential to improving the quality of life of patients, increasing the effectiveness of current treatment and finding remedies for diseases. However, the information on clinical trials is often only available in English and is not always easy to understand.  In response to this situation, the portal created by Esperity provides an effective means of providing patients with information on clinical trials that is always up to date. Following two years of development by Esperity, this portal is now accessible on the websites of the three hospitals (Erasmus Hospital, Jules Bordet Institute and the HUDERF) as well as on the Brussels University Hospital website. There you will find details of the clinical trials being conducted at our three institutions. The launch of this platform marks the beginning of a trajectory that aims to help patents find the best clinical trial and help hospitals find the right patients. An initiative that will also make it possible to speed up the recruitment of patients and contribute to the marketing of safe and effective medicines.   Clinical research, the key to progress in medical knowledge  The commitment of patients is essential to clinical research. Their participation in clinical trials makes it possible to answer important research questions that will subsequently also serve other patients. By participating in a clinical trial, patients whose medical needs are not met can have access to innovative treatment and advanced care dispensed by specialised health professionals. By contributing to research they help progress in medical knowledge that makes it possible to improve treatment for others. Furthermore, in this way patients benefit from personalised follow-up and support that assures them of the best possible care.     A day dedicated to promoting clinical research    Within the three hospitals that make up the Brussels University Hospital a series of actions will take place on Monday 22 May with the aim of promoting clinical research. To find out more about   the Clinicaltrial.be platform or, more generally, for information on how clinical research is organised, come and meet our experts at the information stands located in the three reception halls on Monday 22 May     between 9 am and 5 pm at the Jules Bordet Institute and the Erasmus Hospital   between 10 am and noon and 2 pm and 6 pm at the HUDERF   Further information    Consult the Esperity press release For more information on the clinical trials portal, go to clinicaltrial.be    

Faced with the strike by public sector  workers on 31 January and the directly related issues for public health and society, the French-speaking university hospitals (Brussels University Hospital) (H.U.B), the Saint-Luc University Hospital and the Liège University Hospital) are supporting the unions.   Even if the word is fortunately no longer making the headlines, our hospital system is still suffering from the effects of Copvid-19 and nursing and non-nursing staff are continuing to act every day in a remarkable way in the interests of patients. Action that was very much in the spotlight back in March 2020 and that has since tended to be forgotten. Yet the situation remains difficult on the ground. Apart from the pandemic, the ageing population and the increase in chronic diseases, accompanied by the inevitably more intensive and more complex care, are placing an increasing burden on our healthcare system. With each new health crisis (such as the recent flu and bronchitis epidemic) the system finds itself too often under maximum pressure, despite the solidarity between healthcare staff.     It would be dangerous to accept as normal the reality of a staff shortage that results in many beds being closed.  Alas, there is no denying that working conditions are difficult and that pressure is growing for all concerned. The continuing reduction in hospitalisation days and increase in day hospitalisation operations are in most cases seen as a positive development. However, these trends also place an added burden on nursing staff, especially through the increased rate of new hospital admissions. At the same time, human contact between patients and nurses, so essential to the true meaning of the profession and at the origin of a humane care, is decreasing in parallel.    Then there is the IFC [Job Classification] reform which, despite the intention of greater recognition for nurses, is leading to tensions and frustration on the ground. In fact the reform fails to sufficiently recognise a number of nursing categories, starting with those who work in hospitalisation units or those specialised in complex care units. In addition to the financial aspects, these situations are rightly seen as non-recognition of expertise and of a commitment to patients that is vital to their needs.     The nursing profession is an essential profession and a genuine vocation for many of our colleagues. The hospital sector, a social actor at the heart of every health crisis, has stepped up to face every crisis situation. For this to continue we wish with all our hearts for these professions of such importance and meaning to continue to inspire vocations. Nursing staff play a more than essential role within our university hospitals in which we combine care with research and teaching so as to offer patients the most innovative treatment and to transmit knowledge to future generations. The wealth of discoveries and innovations and the quality of care exist only by virtue of this teamwork between the medical staff and the care staff as a whole.    Working at a university hospital should be one of the most wonderful professions in the world. One that provides the opportunity to be a health actor and to participate actively in the sharing of knowledge and to be present in a scientific and progressive environment dedicated to the highest quality care. Our combat is for the healthcare professions to regain the attractiveness they deserve and that society needs. This is why we have decided to support the trade union organisations on this day of protests.  If the humanism of care is not to become a pious wish it is vital to invest more in improving working conditions, especially by increasing the number of nurses in care units and recognising the specific expertise this requires on their part. We must never forget that it is this collective commitment on the part of nursing staff that enables Belgium to have a healthcare system that is one of our national treasures. Maintaining this exceptional strength means the collective recognition of nurses who, unfortunately, are increasingly having to be subject to a certain aggressiveness on the part of patients or their loved ones.   If collectively, at the political level but also as citizens, we do not make increased recognition for nursing staff an absolute priority we will not be able to retain our present teams and will fail to convince new generations to commit to  the care professions that we all know are so vitally essential.      The Brussels University Hospital (H.U.B) - consisting of the Erasmus Hospital, the Jules Bordet Institute and the Children's Hospital -, the Saint-Luc University Hospital and Liège University Hospital all support the demands of the staff and trade unions as they reflect the general interest. For our hospitals to function optimally and best fulfil their missions of care, research and teaching in an evolving context we support the need for change at the political level for a valorisation of the healthcare professions. One that will render them more attractive and that, more globally, will support the organisation and functioning of our health system.   

Brussels – November 2nd 2023 – This year as every year, the month of November is a month dedicated to increasing awareness of males cancers with the Movember campaign.  Although generally less aware of the fact, men are also at risk of developing a cancer at some point in their lives.  The chances of survival are nevertheless high if the disease is detected at an early stage. At the Brussels University Hospital (H.U.B), comprehensive and personalised care, from prevention to treatment, is available to each and every patient depending on his pathology. The expertise of the teams combined with the latest equipment make it possible to preserve the patient’s quality of life to a maximum.    The “Movember” movement A contraction of “mo” for moustache and November for the month, Movember is an annual event organised by the  Movember Foundation Charity. Every November since 2003, men across the globe are invited to grow a moustache. The aim is twofold: to increase public awareness of men’s health and to raise funds for research into such male diseases as prostrate or testicular cancer.    Join the movement and become a “Mo Bro”!  The importance of prevention We are not all equal in the face of cancer.  Independently of lifestyle, the risk varies depending on our genetic makeup.  Some genetic mutations bring an increased risk. Similarly, a family history of cancers or personal antecedents increase an individual’s risk.  In 2022, 40 335 cancers were diagnosed in men in Belgium, with 12 732 cases of prostate cancer that remains the most common male cancer. But for the vast majority of people with an average risk, the proportion of “avoidable” cancers is 30-40%.    There are two main components of prevention: lifestyle and screening. The recommended lifestyle measures are summed up in the European Code Against Cancer: don’t smoke, drink less, eat better, remain active and watch your weight.  Making an appointment at the Jules Bordet Institute’s Screening Clinic for a thorough check up is also an effective way of preventing cancers and detecting them in time.    360° care at the H.U.B At the H.U.B, patients with a male cancer are cared for by a multidisciplinary team including urologists, nurses, oncologists, radiotherapists and psychologists. The aim is to provide comprehensive personalised care for every male patient. The expertise of each professional combined with the latest technology serves to treat the tumour effectively while maintaining the patient’s quality of life with the fewest possible side effects and complications  Effective technology From diagnosis to treatment, our machines and techniques meet the needs of patients with ultimate precision:    Transperineal biopsy (through the perineal skin rather than the rectum) involves taking a sample of several prostrate fragments using a needle. The H.U.B is one of the few hospitals to practice this technique under local anaesthetic.    PET/MRI is a hybrid imaging technique that combines TEP and MRI for ultimate biopsy precision.    PSMA PET scan is metabolic imaging   that permits a more precise visualisation of cancer lesions than is possible with conventional imaging.  A robotic platform  permits minimally invasive interventions (the famous surgical robot).  Focused ultrasound (Focal-One) provides ablative treatment limited to small prostate tumours that are not very aggressive and that allows the gland to be saved  The  MRI-Linac is a radiotherapy machine that in 5 sessions provides a curative treatment of certain prostate cancers with a significant reduction in toxicity.  Theranostics  is a combination of precise diagnosis using metabolic imaging and at the same time treatment of the lesions found.  

On the occasion of World Sickle Cell Day on 19 June, the Erasmus Hospital and the HUDERF, national and European reference centres for sickle cell disease within the Brussels University Hospital (H.U.B), are focusing on the disease. Among care staff as well as the general public, received ideas regarding this disease, its symptoms and its complications fuel a series of prejudices resulting in social exclusion as well as difficulty in stimulating the blood donations needed to transfuse these patients. In Belgium almost 90% of sickle cell disease patients require regular blood transfusions.   Sickle cell disease: combating received ideas to encourage access to specialised care Sickle cell disease is a genetic disease of the blood that affects 1 child for every 2,329 births. Particularly frequent among populations of Caribbean, African and Mediterranean origin, it is the commonest genetic disease in Belgium. It is characterised by a deformation of the red blood cells that results in severe anaemia, a local obstruction in the blood circulation and a reduction in the oxygen supply to several vital organs. A child with sickle cell disease has episodes of extreme pain, periods of acute anaemia and is much more prone to serious infections. Complications of this rare multisystemic disease can affect the brain, heart, lungs, kidneys, bones and eyes. These become established over time, increase in frequency in adulthood and have a major impact on comorbidities and mortality. Since January 2023 sickle cell disease has been one of the diseases detected by the Guthrie test in the Wallonia-Brussels Region, this making it possible to identify and treat patients at an early stage of the disease within a reference centre. Hydroxyurea, chronic transfusion and bone marrow transplants are at present the only treatments available in Belgium that modify the symptoms of the disease to reduce complications and improve the quality of life of patients. The sole curative option is to transplant stem cells (bone marrow) but its applications are limited. Two reference centres and expert professions within the H.U.B to support the sickle cell patient This rare and complex disease requires treatment at specialised centres such as the HUDERF and Erasmus Hospital, both recognised as reference centres for rare diseases of the red blood cell at national and European level since 2017. More than a third of patients on the sickle cell disease register in Belgium are being followed up by the H.U.B for the treatment by multidisciplinary teams of the various aspects of this disease. Our haematologists are central to the clinical biological follow-up, treatment and prevention of complications. The referring nurses, essential links in ensuring awareness and an effective response to a patient's needs, coordinate the care and the professionals who provide it. Our biologists play a major role in screening and boosting awareness of the risk of transmission to children. Finally, our psychologists, dietitians and social workers pay special attention to pain management, emotional support, well-being and diet. For children and adolescents, supporting the child in his or her psychological, social, school and family reality is a central element of care in encouraging the development of autonomy despite the illness as well as adherence to treatment and knowledge of the disease. It is essential to help the child to acquire the awareness and know-how to continue to look after themselves throughout their life, with the solid support of medical teams in an adult environment. Rare blood donation and the search for new drugs are the top priorities Most sickle cell patients will need a blood transfusion at some point. Some of them will need regular transfusions throughout their life. Hence the supply problems. The transfused blood must match as closely as possible that of the sickle cell patients who have blood groups that can be rare in Belgium. At present we regularly face shortages and that is particularly true for the blood groups found predominantly among non-Caucasian populations. Treating sickle cell patents is a daily battle and it is essential to continue research into developing new treatments. A number of clinical trials involving medicines are proposed for both adults and children and especially in the field of cell therapy, with gene therapy a promising avenue for curing rare diseases of the red blood cell. Make a blood donation To assist sickle cell patients, a campaign for rare blood donations focusing on sickle cell disease is being launched by our teams within the hospital and on social networks. To give blood, please go to the Erasmus Hospital Blood Donation Centre or donate via any Red Cross blood donation center. Save the date! Festival Drépanocyt’OSE from 17 to 19 June at Tour & Taxis During the weekend of 17 June 2023, associations active in the field of combating sickle cell disease are organising a festival to increase public awareness of the disease. Experts from the Erasmus Hospital and the Children's Hospital will also be there to represent professionals from the H.U.B. Saturday 18 June from 1 pm to 5 pm at our stand at Tour et Taxis Monday 19 June, World Sickle Cell Day, during the conference at Tour & Taxis For more information: https://www.festival-drepanocytose.com    

If you want to share your medical data and access your file. The hospital is a member of the Brussels Health Network, an information sharing network that links up all Brussels and Belgian hospitals with GPs and brings together certain medical records. By agreeing to share the file on your child you allow doctors to have immediate access to his or her medical records and to ensure a quality follow up. For all information about access to your health data, visit: MaSanté.be. If you are already a member of the network, you can consult your medical records or the medical records of your underage child at any time by connecting to the same platform.  Visit MaSanté.be Discover the Brussels Health Network

Join us at the H.U.B!   When you work at the Erasmus Hospital you are joining a renowned academic institution and also, by extension, the Brussels University Hospital (H.U.B) – a grouping of the Jules Bordet Institute, the Queen Fabiola Children’s University Hospital (HUDERF) and the Erasmus Hospital.    This strong union has 1,420 beds and more than 6,000 staff, including almost 980 doctors and close to 4,000 non-medical staff deployed across two university campuses: Anderlecht and Laeken.    Today we are seeking new talents in all fields: medical, nursing and paramedical, technical, logistics, administrative, etc.    Is the patient’s interest your top priority? Discover our job opportunities and apply here! Our vacancies Our advantages The H.U.B aims to provide all its personnel with a fulfilling and attractive work environment with opportunities for training and career development. In addition to an attractive salary, at the Erasmus Hospital you will also enjoy many fringe benefits. There is a metro link to the hospital and free parking on site. Image Image Image Our advantages : nursing department Offering high-quality care using cutting-edge technologyAn attractive salary packageMeal vouchers200% extra pay for work from Saturday 2pm to Monday 7amReimbursement of transport costsGroup insuranceAccess to healthcare at a preferential rate29.5 days annual leave12 compensatory days if working 40 hours a weekAccess to ongoing training  Image Image Image